Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80
Organisation › Details

Immunexpress (Group)

Immunexpress is a Seattle-based molecular diagnostic company committed to improving outcomes for patients suspected of sepsis. Immunexpress' SeptiCyte™ technology rapidly quantifies, directly from whole blood, specific molecular markers from the patient's own immune system – the "host response." Detecting the host's response to infection has the potential to differentiate systemic inflammatory response syndrome (SIRS) from sepsis earlier, faster and more accurately than finding the invading pathogen, thus enabling appropriate patient management without delay. Immunexpress' pipeline includes several sample-to-answer assays for near-patient testing. *


Period Start 2014-03-12 existent
Products Industry PCR test (clinical diagnostics)
  Industry 2 sepsis test
Persons Person Brandon, Roslyn (Immunexpress 201403 CEO)
  Person 2 Papadaki-Markley, Jane (Immunexpress 201909– VP Market Development + Commercial before Wafergen + ApoCell + Asuragen)
Region Region Seattle, WA
  Country United States (USA)
  Street 425 Pontius Avenue North
Suite 430
  City 98109 Seattle, WA
  Tel +1-206-858-6436
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: Immunexpress, Inc.. (10/3/19). "Press Release: Immunexpress Announces Closing of Private Funding Round". Seattle, WA.
Record changed: 2020-03-14


Picture [iito] Plain Stupid Simple 650x80px

More documents for Immunexpress (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81

» top